Home >> Signaling Pathways >> Metabolism >> Necroptosis

Necroptosis

Products for  Necroptosis

  1. Cat.No. Product Name Information
  2. GC52126 8-chloro Caffeine

    NSC 6277

    8-chloro Caffeine  Chemical Structure
  3. GC65004 Apostatin-1

    Apt-1

    Apostatin-1 (Apt-1) is a potent TRADD inhibitor. Apostatin-1  Chemical Structure
  4. GC43022 C14 Ceramide (d18:1/14:0)

    Cer(d18:1/14:0)

    C14 Ceramide is an endogenous ceramide generated by ceramide synthase 6.

    C14 Ceramide (d18:1/14:0)  Chemical Structure
  5. GC49556 Cl-Necrostatin-1

    7-Cl-Nec-1, 7-Cl-Necrostatin-1, Nec-1f

    A RIPK1 inhibitor Cl-Necrostatin-1  Chemical Structure
  6. GC69345 KWCN-41

    KWCN-41 is a selective and efficient inhibitor of RIPK1 kinase with an IC50 value of 88 nM. KWCN-41 specifically inhibits necroptosis but does not inhibit apoptosis. KWCN-41 also has anti-inflammatory effects.

    KWCN-41  Chemical Structure
  7. GC40497 Necrostatin-1 Inactive Control

    Nec-1i

    Necrostatin-1 Inactive Control (Nec-1i) is a demethylated variant of necrostatin-1, a RIP1 kinase inhibitor.

    Necrostatin-1 Inactive Control  Chemical Structure
  8. GC44359 Necrostatin-7

    Nec7

    Necroptosis is a regulated caspase-independent cell death mechanism that results in morphological features resembling necrosis. Necrostatin-7  Chemical Structure
  9. GC49681 Necrosulfonamide-d4

    NSA-d4

    Necrosulfonamide-d4 is the deuterium labeled Necrosulfonamide. Necrosulfonamide is a necroptosis inhibitor acting by selectively targeting the mixed lineage kinase domain-like protein (MLKL). Necrosulfonamide prevents MLKL-RIP1-RIP3 necrosome complex from interacting with its downstream effectors. MLKL is a critical substrate of RIP3 during the induction of necrosis. Necrosulfonamide-d4  Chemical Structure
  10. GC49308 Ungeremine

    Lycobetaine

    A betaine-type alkaloid with diverse biological activities Ungeremine  Chemical Structure

9 Item(s)

per page

Set Descending Direction